Think Bioscience Raises $55M in Oversubscribed Series A
Funding will advance the company’s internal pipeline of first-in-class programs BOULDER, Colo., Jan. 20, 2026 /PRNewswire/ — Think Bioscience (“Think Bio”), a biotechnology company focused on unlocking elusive drug targets, has raised $55M in an oversubscribed Series…